BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19758521)

  • 21. An employer's dilemma: grappling with health benefits.
    Walters DE; Yang B
    Dis Manag; 2003; 6(Suppl 1):S13-4. PubMed ID: 14751023
    [No Abstract]   [Full Text] [Related]  

  • 22. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The direct and indirect costs of untreated insomnia in adults in the United States.
    Ozminkowski RJ; Wang S; Walsh JK
    Sleep; 2007 Mar; 30(3):263-73. PubMed ID: 17425222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
    Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
    Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health problems cost billions in lost productivity.
    Med Health; 2005 Sep; 59(32):5-6. PubMed ID: 16193934
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparing costs and absences for multiple sclerosis among US employees: pre- and post-treatment initiation.
    Rajagopalan K; Brook RA; Beren IA; Kleinman NL
    Curr Med Res Opin; 2011 Jan; 27(1):179-88. PubMed ID: 21138336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing behavioral health care: an employer's perspective.
    Davidson BN
    J Clin Psychiatry; 1998; 59 Suppl 2():9-12. PubMed ID: 9559754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The direct economic costs of insomnia in the United States for 1995.
    Walsh JK; Engelhardt CL
    Sleep; 1999 May; 22 Suppl 2():S386-93. PubMed ID: 10394612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect costs among employees with diabetic retinopathy in the United States.
    Lee LJ; Yu AP; Cahill KE; Oglesby AK; Tang J; Qiu Y; Birnbaum HG
    Curr Med Res Opin; 2008 May; 24(5):1549-59. PubMed ID: 18416887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The costs of cancer to a major employer in the United States: a case-control analysis.
    Barnett A; Birnbaum H; Cremieux PY; Fendrick AM; Slavin M
    Am J Manag Care; 2000 Nov; 6(11):1243-51. PubMed ID: 11185849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs of asthma among US working adults.
    Shenolikar R; Song X; Anderson JA; Chu BC; Cantrell CR
    Am J Manag Care; 2011 Jun; 17(6):409-16. PubMed ID: 21756011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care trends in today's marketplace.
    Berger J; Dauten MS
    Empl Benefits J; 1999 Dec; 24(4):11, 13-6. PubMed ID: 10662385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The employer's case for health management.
    Coulter CH
    Benefits Q; 2006; 22(1):23-33. PubMed ID: 16792389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drug benefits: Rx for cost management--commentary.
    Carlsen MA
    Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207
    [No Abstract]   [Full Text] [Related]  

  • 36. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
    Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
    Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health and disability costs of depressive illness in a major U.S. corporation.
    Druss BG; Rosenheck RA; Sledge WH
    Am J Psychiatry; 2000 Aug; 157(8):1274-8. PubMed ID: 10910790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating quantitative and qualitative approaches to assess wintertime illness-related absenteeism and its direct and indirect costs among the private sector in Ulaanbaatar.
    Ganbat M; Erdenebileg N; Batbold C; Nergui S; Anderson R; Wigfall C; Amarsanaa N; Heikens A; Sarantuya M; Warburton D
    PLoS One; 2022; 17(2):e0263220. PubMed ID: 35113912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs to business for an HIV-infected worker.
    Farnham PG; Gorsky RD
    Inquiry; 1994; 31(1):76-88. PubMed ID: 8168911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benchmarking health and disability benefits in the energy and communications industries.
    Tortarolo JS; Polakoff PL
    Benefits Q; 1995; 11(1):38-45. PubMed ID: 10141995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.